• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury

tetano

Editor, Senior Moderator
Lung. 2018 Aug 30. doi: 10.1007/s00408-018-0154-2. [Epub ahead of print]
[h=1]TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury.[/h] Allen JR[SUP]1[/SUP], Ge L[SUP]1[/SUP], Huang Y[SUP]1[/SUP], Brauer R[SUP]1[/SUP], Parimon T[SUP]1[/SUP], Cassel SL[SUP]1[/SUP], Sutterwala FS[SUP]1[/SUP], Chen P[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] Influenza infects millions of people each year causing respiratory distress and death in severe cases. On average, 200,000 people annually are hospitalized in the United States for influenza related complications. Tissue inhibitor of metalloproteinase-1 (TIMP-1), a secreted protein that inhibits MMPs, has been found to be involved in lung inflammation. Here, we evaluated the role of TIMP-1 in the host response to influenza-induced lung injury.
[h=4]METHODS:[/h] Wild-type (WT) and Timp1-deficient (Timp1[SUP]-/-[/SUP]) mice that were 8-12 weeks old were administered A/PR/8/34 (PR8), a murine adapted H1N1 influenza virus, and euthanized 6 days after influenza installation. Bronchoalveolar lavage fluid and lungs were harvested from each mouse for ELISA, protein assay, PCR, and histological analysis. Cytospins were executed on bronchoalveolar lavage fluid to identify immune cells based on morphology and cell count.
[h=4]RESULTS:[/h] WT mice experienced significantly more weight loss compared to Timp1[SUP]-/-[/SUP] mice after influenza infection. WT mice demonstrated more immune cell infiltrate and airway inflammation. Interestingly, PR8 levels were identical between the WT and Timp1[SUP]-/-[/SUP] mice 6 days post-influenza infection.
[h=4]CONCLUSION:[/h] The data suggest that Timp1 promotes the immune response in the lungs after influenza infection facilitating an injurious phenotype as a result of influenza infection.


[h=4]KEYWORDS:[/h] Acute lung injury; Influenza; PR8; Timp1

PMID: 30167842 DOI: 10.1007/s00408-018-0154-2
 
Back
Top Bottom